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Objectives: In order to clarify the transmission cycle and genetic identity of Borrelia spirochetes in the
non-endemic country of Taiwan, the causative agents responsible for human borreliosis were isolated
from skin biopsies of patients and their genetic identities were determined.
Methods: Serum samples and skin biopsy specimens were collected from 95 patients: 85 with suspected
Lyme disease and 10 controls. Infection with Borrelia burgdorferi was veriﬁed by Western immunoblot
analysis and isolation of the Borrelia spirochetes from skin biopsy specimens. The genetic identities of
these isolated spirochetes were determined by analyzing the gene sequences ampliﬁed by polymerase
chain reaction assay based on the 5S (rrf)–23S (rrl) intergenic spacer amplicon gene of B. burgdorferi
sensu lato.
Results: Serological evidence of B. burgdorferi infection was conﬁrmed by elevated IgG and IgM
antibodies against the major protein antigens of B. burgdorferi. Borrelia spirochetes were isolated from
the skin biopsies of two patients. Phylogenetic analysis revealed that these detected spirochetes were
genetically afﬁliated to the genospecies Borrelia burgdorferi sensu stricto and Borrelia afzelii, with a high
sequence homology within the genospecies of B. burgdorferi sensu stricto (98.7–100%) and B. afzelii
(100%), respectively.
Conclusions: This study provides convincing evidence of B. burgdorferi sensu stricto and B. afzelii isolated
and identiﬁed for the ﬁrst time in Taiwan, and highlights the signiﬁcance of genetic diversity of Borrelia
spirochetes among patients in Taiwan.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Lyme disease (LD) is an emerging tick-borne spirochete infection
that can cause multisystem human illness with varying degrees
of clinical symptoms among infected persons, ranging from a
relatively benign skin lesion to severe arthritic, neurologic, and
cardiac manifestations.1 Based on the clinical manifestations in
patients and the pathogenicity to humans, the causative agent of
Lyme disease can be classiﬁed into four major genospecies: Borrelia
burgdorferi sensu stricto, Borrelia garinii, Borrelia afzelii, and Borrelia
spielmanii.2–4 Although spirochetes of B. burgdorferi sensu stricto
have been isolated from six species of rodent host5 and detected in
Ixodes granulatus ticks in Taiwan,6 this genospecies of Borrelia
spirochete has never been isolated or identiﬁed from human tissues
in Taiwan.
Genomic analysis of Borrelia isolates by sequence similarity of a
speciﬁc target gene has proven useful for species identiﬁcation and
genomic typing of Borrelia spirochetes isolated from different* Corresponding author. Tel.: +886 2 87923152; fax: +886 2 87921821.
E-mail address: cmshih@ndmctsgh.edu.tw (C.-M. Shih).
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intergenic spacer amplicon gene is unique and highly conserved in
B. burgdorferi sensu lato.10,11 The diversity of this gene is useful for
distinguishing the genetic heterogeneity among different Borrelia
isolates.12–14 Indeed, the genetic identity of Borrelia spirochetes
can be clariﬁed by analyzing the sequence homology of 5S (rrf)–
23S (rrl) intergenic spacer amplicon genes of B. burgdorferi sensu
lato isolated from various biological sources,15,16 including patient
skin specimens.17,18
Thus, the objective of this study was to identify the genospecies
of Borrelia spirochetes isolated from the skin biopsies of indigenous
human cases by analyzing the sequence similarities of PCR-
ampliﬁed 5S (rrf)–23S (rrl) intergenic spacer amplicon genes. In
addition, the phylogenetic relationships of these detected spir-
ochetes were compared with other Borrelia species that have been
documented in GenBank.
2. Materials and methods
2.1. Patient history and specimen collection
Weconducted an investigation for B. burgdorferi infection among
patients with clinical manifestations suggestive of Lyme disease.ses. Published by Elsevier Ltd. All rights reserved.
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the National Taiwan University Hospital; there were 42 cases with
erythema annulare, 20 cases withmorphea, 14 cases with urticaria,
two cases with lymphocytoma cutis, ﬁve cases with prurigo
pigmentosa, two cases with granuloma annulare, and 10 healthy
control patients. Among the suspected cases, two native Taiwanese
patients visited the dermatology clinic with the chief complaint of
long-lasting skin lesions observed on their body. These skin lesions
hadbeenpresent for3–5years followinga suspected arthropodbite.
There was no history of travel to other countries during the past 10
years for either of these patients. Based on their clinical features, the
skin lesions were diagnosed as morphea-like (or localized sclero-
derma) cutaneous manifestations. Skin biopsies were collected for
cultivating of Borrelia spirochetes. Serum specimens were subse-
quently collected from the same patients and tested for serological
evidence of B. burgdorferi infection.
2.2. Serodiagnosis of B. burgdorferi infection
Serodiagnosis of Lyme disease infection was performed with a
screening test by indirect immunoﬂuorescence assay (IFA),
followed by Western immunoblot (WB) analysis using paired sera
collected from the same patient, as recommended by the US
Centers for Disease Control and Prevention (US CDC).19 Brieﬂy, ﬁve
strains of Borrelia spirochete (strains B31, TWKM1, TWKM5, K48,
and VS461) from pure cultures were used as antigens for both IFA
and WB analysis, as previously described.5,20 Electrophoresed
Borrelia proteins were transferred from the sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) gels to nitrocellu-
lose blotting membranes using a semi-dry electroblotter (Phast-
Transfer electrode cassette; Pharmacia Biotech). The transferred
membranes were blocked for 2 h with 3% gelatin in Tris-buffered
saline (TBS, pH 7.5) containing 20 mM Tris and 500 mM NaCl, and
then incubated for 2 h at room temperature in a 1:20 dilution of
serum specimens. After being washed with buffer solution, the
membraneswere further immersed for 2 h in alkaline phosphatase
(AP)-conjugated goat anti-human IgG (catalog No.109-055-008;
Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA)
and IgM (catalog No. 109-055-043; Jackson ImmunoResearch
Laboratories Inc.) diluted 1:5000 with 0.05% Tween 20 in TBS (T-
TBS), as previously described.20 The reactedmembranes were then
washed twice with T-TBS, and a substrate solution (10 ml of
nitroblue tetrazolium; catalog No. B5655; Sigma Co., St. Louis, MO,
USA) was added to develop the color for 1 min; the reacted
membranes were then washed with distilled water and air-dried
for analysis of spirochete protein bands.
2.3. Isolation and cultivation of Borrelia spirochetes
For isolation of spirochetes, patient skin biopsy specimens
(measuring 2–4 mm in diameter) were cleaned with a 75% ethanol
solution for 1–2 min and then washed twice in sterile distilled
water. Next, individual skin specimens were dissected into pieces
and inoculated into a culture tube containing BSK-H medium
(catalog No. B3528; Sigma) supplemented with 6% rabbit serum
(catalog No. R7136; Sigma), as previously described.5 After
incubation at 34 8C in a humidiﬁed incubator (Sanyo Electric
Biomedical Co., Ltd, Osaka, Japan) with 5% CO2, skin cultures were
examined weekly for 8 weeks by dark-ﬁeld microscope (BX-60,
Olympus Co., Tokyo, Japan) for evidence of spirochetes. For
puriﬁcation of cultivable spirochetes, spirochete-positive cultures
with other contaminants were transferred to new culture tubes by
serial dilution and were further ﬁltered with 0.45-mm pore-size
syringe ﬁlters (Sartorius, Gottingen, Germany), as previously
described.5 In addition, all the spirochete-positive cultures were
also stored frozen (80 8C) for further investigation.2.4. DNA extraction from skin cultures
Total genomic DNA was extracted from individual spirochete-
positive cultures using the DNeasy Tissue Kit (catalogue No. 69506;
Qiagen, Taipei, Taiwan) and used as template for polymerase chain
reaction (PCR) ampliﬁcation. Brieﬂy, individual positive-cultured
media togetherwithdissected skinwereplaced in amicrocentrifuge
tube and centrifuged for 20 min at 12 000  g to pellet the
spirochetes. After removing the supernatant, the microcentrifuge
tube was ﬁlled with 180ml lysing buffer solution and was further
processed by DNeasy Tissue Kit, as per the manufacturer’s
instructions. After ﬁltration, the eluate was collected and the DNA
concentration was determined spectrophotometrically with a DNA
calculator (GeneQuant II; Pharmacia Biotech, Uppsala, Sweden).
2.5. DNA ampliﬁcation by Borrelia-speciﬁc PCR
A nested PCR was performed with primers designed to amplify
the variable spacer region between two conserved duplicate
structures. A primer set corresponding to the 30 end of the 5S rRNA
(rrf) (50-CGACCTTCTTCGCCTTAAAGC-30) and the 50 end of the 23S
rRNA (rrl) (50-TAAGCTGACTAATACTAATTACCC-30) was designed
and applied for the primary ampliﬁcation, as previouslydescribed.11
In the nested PCR, a primer set of primer 1 (50-CTGCGAGTTCGCGG-
GAGA-30) and primer 2 (50-TCCTAGGCATTCACCATA-30) was used
and expected to yield a 226–266-bp fragment depending on the
Borrelia strain, as previously described.21 All PCR reagents and Taq
polymerase were obtained and used as recommended by the
manufacturer (Takara Shuzo Co., Ltd, Japan). Brieﬂy, a total of
0.2mmol of the appropriate primer set and various amounts of
template DNA were used in each 50-ml reaction mixture. PCR
ampliﬁcation was performed with a Perkin-Elmer Cetus thermo-
cycler (GeneAmp system 9700; Taipei, Taiwan), and the primary
ampliﬁcation included 2 min denaturation at 96 8C, followed by 30
cycles of the following conditions: denaturation at 94 8C for 30 s,
annealing at 55 8C for 30 s, and extension at 72 8C for 40 s. Nested
ampliﬁcation was performed under the same conditions, except for
annealing at 59 8C for 30 s. Next, PCR-ampliﬁed DNA products were
electrophoresed on 2% agarose gels in Tris–borate–EDTA (TBE)
buffer andwere visualizedunder ultraviolet (UV) light after staining
with ethidium bromide. A DNA ladder (1-kb plus, catalogue No.
10787-018; Gibco BRL, Taipei, Taiwan) was used as the standard
marker for comparison. A negative control of distilled water was
included in parallel with each ampliﬁcation.
2.6. Sequence alignments and phylogenetic analysis
After puriﬁcation (QIAquick PCR puriﬁcation kit; catalogue No.
28104), sequencing reactions were performed by a dye-deoxy
terminator reaction method using the Big Dye Terminator Cycle
Sequencing Kit under an ABI Prism 377-96 DNA sequencer (Applied
Biosystems, Foster City, CA, USA). The resulting sequences were
initially alignedwithCLUSTALWsoftware22and further analyzedby
comparing with other Borrelia sequences that were available in
GenBank. Neighbor-joining (NJ) compared with maximum parsi-
mony (MP) methods were used to estimate the phylogeny of the
entire alignment using MEGA 4.0 software package.23 A similarity
matrix was also constructed using DNASTAR program (Lasergene,
version 8.0). All phylogenetic treeswere constructed andperformed
with 1000 bootstrap replications to evaluate the reliability of the
constructions, as described previously.24
2.7. Nucleotide sequence accession numbers
The nucleotide sequences of the PCR-ampliﬁed 5S (rrf)–23S (rrl)
intergenic spacer amplicon genes from Borrelia spirochetes
Table 1
Genospecies and strains of Borrelia spirochetes used for phylogenetic analysis in
this study
Genospecies and strain Origin of Borrelia strain 5S (rrf)–23S
(rrl) gene
accession
numbera
Biological Geographic
Taiwan strain
Bbss-MP-TW Human skin Taiwan GQ499848
Ba-MP-TW Human skin Taiwan GQ499849
B. burgdorferi sensu stricto
B31 Ixodes scapularis USA L30127
TWKM5 Rattus norvegicus Taiwan AY032908
IP1 Human CSF France AF090977
Sh-2-82 Ixodes dammini USA DQ393307
297 Human CSF USA AJ006507
B. garinii
20047 Ixodes ricinus France L30119
NP81 Ixodes persulcatus Japan D84406
B. afzelii
VS461 Ixodes ricinus Switzerland L30135
BO23 Human skin Sweden Z77174
J1 Ixodes persulcatus Japan L30129
TN2 Ixodes ricinus Italy DQ860258
B. bissettii
DN127 Ixodes paciﬁcus USA L30126
CA376 Neotoma fuscipes USA AY177634
B. spielmanii
A14S Human skin the Netherlands U76616
PC-Eq17N5 Ixodes ricinus France DQ133526
PC-Eq2rN8 Ixodes ricinus France DQ133528
B. valaisiana
VS116 Ixodes ricinus Switzerland L30134
CKA2a Apodemus agrarius China AB022124
UK Ixodes ricinus England L30133
B. sinica
CMN3 Niviventer sp China AB022131
CWO1 Ixodes ovatus China AB022130
CMN1a Niviventer sp China AB022129
CSF, cerebrospinal ﬂuid.
a GenBank accession numbers GQ499848 and GQ499849were submitted by this
study.
L.-L. Chao et al. / International Journal of Infectious Diseases 15 (2011) e182–e187e184determined in this study have been registered and assigned the
following GenBank accession numbers: GQ499848 (strain Bbss-
MP-TW) and GQ499849 (strain Ba-MP-TW). For phylogenetic
analysis, the nucleotide sequences of 5S (rrf)–23S (rrl) intergenic
spacer amplicon genes from various Borrelia species were included
for comparison, and their GenBank accession numbers are shown
in Table 1.
3. Results
3.1. Serological evidence of B. burgdorferi infection
Serodiagnosis of B. burgdorferi infection in our patients was
made by screening with the IFA test, with a positive reactivityTable 2
Clinical characteristics of two patients and laboratory analysis for B. burgdorferi infecti
Patient sex/age (years) Clinical features Reactivity b
immunoblo
Female/16 Morphea-like skin lesion (3 years) IgG: 30, 41,
IgM: 45, 58
Male/33 Morphea-like skin lesion (5 years) IgG: 30, 41,
IgM: 41 kDa
a Genospecies identiﬁcation based on 5S (rrf)–23S (rrl) intergenic spacer amplicon g(>1:40) against Borrelia spirochetes, and conﬁrmed byWB analysis
with the presence of several major antigenic proteins that are
known to be correlated with B. burgdorferi infection. As shown in
Table 2, WB analysis using paired sera collected from the same
patient revealed elevated IgG and IgM antibodies against themajor
protein antigens of B. burgdorferi. In one patient, signiﬁcant IgG
reactivities with the 30, 41, 45, 58, and 66 kDa protein antigens of
B. burgdorferi were observed, with signiﬁcant IgM reactivities
against the 45, 58, and 66 kDa protein bands of B. burgdorferi
(Table 2). A second patient showed signiﬁcant IgG reactivities with
the 30, 41, 45, 58, 63, and 66 kDa protein antigens of B. burgdorferi;
however, IgM reactivity showed only the 41 kDa protein band of B.
burgdorferi.
3.2. Isolation of Borrelia spirochetes from patient skin biopsies
Cultivation of skin biopsies from patients with chronic skin
lesions demonstrated B. burgdorferi-like spirochetes at 16 to 24
days after initial inoculation (Table 2). Puriﬁcation of cultivable
spirochetes was performed by serial dilution of ﬁltrated cultures,
and pure isolates of B. burgdorferi-like spirochetes were also
observed in culture medium at 3–7 days after ﬁltrated passage. To
obtain sufﬁcient quantity of cultivable spirochetes, all positive
cultures were allowed to grow in BSK-H medium for a further 2
weeks.
3.3. Genetic identiﬁcation and phylogenetic analysis of isolated
spirochetes
To clarify the genetic identity of Borrelia-like spirochetes, we
employed a nested PCR assay to achieve a high sensitivity and
speciﬁcity for Borrelia detection. In this study, nested PCR assays
revealed ampliﬁed DNA fragments of approximately 250 bp from
skin cultures of infected patients (Figure 1). Based on the
comparison of 5S–23S intergenic spacer amplicon gene sequences
among 24 Borrelia spirochetes, the genetic identities of strains
Bbss-MP-TW and Ba-MP-TW isolated from patient skin were
veriﬁed with a high sequence homology within the genospecies of
B. burgdorferi sensu stricto (98.7–100%) and B. afzelii (100%),
respectively (Table 3). Phylogenetic analysis also revealed that
these detected spirochetes represented two monophyletic groups
closely afﬁliated to the genospecies of B. burgdorferi sensu stricto
and B. afzelii, and constituted two separate clades distinguished
clearly from other Borrelia genospecies by both the neighbor-
joining and maximum parsimony methods (Figure 2).
4. Discussion
This report provides the ﬁrst convincing evidence of B.
burgdorferi sensu stricto and B. afzelii spirochetes isolated from
human tissue in Taiwan. In our previous study, Lyme disease
spirochetes (B. burgdorferi sensu stricto) were isolated from rodent
hosts captured at various locations in Taiwan,5 and the I. granulatus
tick was recognized as the incriminated vector tick for enzoonotic
transmission of Borrelia spirochetes in Taiwan.6 In addition to theon
ands by Western
t test
Borrelia culture Borrelia species identiﬁeda
45, 58, 66 kDa
, 66 kDa
Positive at 24 days B. afzelii
45, 58, 63, 66 kDa Positive at 16 days B. burgdorferi sensu stricto
ene of B. burgdorferi sensu lato.
[(Figure_1)TD$FIG]
Figure 1. Ampliﬁcation of Borrelia DNA from patient skin cultures by nested PCR
assay based on the 5S (rrf)–23S (rrl) rRNA gene. Lanes: M, molecular marker; 1–5,
patients characterized with morphea-like skin lesions; N, negative control.
L.-L. Chao et al. / International Journal of Infectious Diseases 15 (2011) e182–e187 e185discovery of human borreliosis in Taiwan,25–27 isolation and
identiﬁcation of the causative agents responsible for B. burgdorferi
infection from patient tissue is required to clarify the transmission
cycle of Borrelia spirochetes in Taiwan. Indeed, results from the
present study conﬁrm the existence of Borrelia spirochetes in
human skin biopsies and demonstrate that the detected spir-
ochetes are genetically afﬁliated to the genospecies of B.
burgdorferi sensu stricto and B. afzelii. Further investigations
focused on the detection of Borrelia spirochetes among patients
with various clinical manifestations would help to elucidate the
genetic polymorphism of Borrelia spirochetes in Taiwan.
The US CDC requires the two-test approach for a positive
diagnosis,19 however the European Union Concerted Action on
Lyme Borreliosis (EUCALB) requires only two seroreactive bands
among 10major Borrelia protein antigens for IgGWB, and only one
seroreactive band among threemajor Borrelia protein antigens (17,
23, and 39 kDa) or a strong 41 kDa band for IgM WB for a positive
diagnosis.28 Thus, our patients met the deﬁned requirements for a
positive seroconversion associated with B. burgdorferi infection
according to the diagnostic criteria of both theUS CDC and EUCALB.
The differential WB banding in infected patients may be
attributed to the variable seroreactivity of the patient’s serum
against Borrelia protein antigens. Indeed, a previous study on the
frequency ofWB reactivity to speciﬁc Borrelia protein antigens also
revealed that seroreactivity of IgG antibody against the higher
molecular weight mass bands (41 kDa and above) was most
frequently detected in infected patients.29 Results from the present
cases also revealed signiﬁcant seroreactivities of IgG and IgM
antibodies against the higher molecular weight mass bands of
Borrelia protein antigens (Table 2). Moreover, the present casesTable 3
Sequence similarity between 5S (rrf)–23S (rrl) gene sequences from Taiwan strains iso
Spirochete strain B31 Bbss-MP-TW TWKM5 Sh-2-82 VS461 Ba
B31 – 99.6 99.6 98.7 86.7 86
Bbss-MP-TW – 100 99.1 87.1 87
TWKM5 – 99.1 87.1 87
Sh-2-82 – 87.1 87
VS461 – 10
Ba-MP-TW –
BO23
J1
20047
DN127
VS116
A14S
CMN3
a Strains: B31, TWKM5 and Sh-2-82, B. burgdorferi sensu stricto; VS461, BO23 and J1, B
CMN3, B. sinica.also showed the persistence of elevated anti-B. burgdorferi IgG and
IgM antibody titers during the prolonged infection course. These
results demonstrate the signiﬁcance of persistent differential
seroreactivity of individual patients against Borrelia protein
antigens. Further investigations focused on the variant seroreac-
tivities of WB banding in infected patients veriﬁed by cultured
spirochetes would be beneﬁcial to establish standardized criteria
for the serodiagnosis of B. burgdorferi infection in Taiwan.
The spirochete infection was also veriﬁed by the presence of
cultivable spirochetes in skin cultures. Although in vitro isolation
of Borrelia spirochetes from infected tissues is not sensitive, culture
of B. burgdorferi sensu lato undoubtedly provides the best
conﬁrmation of active infection. Indeed, cultivation of skin biopsy
specimens gives the highest success rate for clinical samples,30,31
and successful recovery of B. burgdorferi spirochetes has been
reported from patients with late cutaneous manifestations more
than 10 years after the onset of the skin lesion.32 Results from the
present cases also revealed a positive cultivation of Borrelia
spirochetes from skin biopsy specimens of infected patients with
long-lasting skin lesions, more than 3–5 years after the onset.
Indeed, B. burgdorferi-like spirochetes were observed in skin
cultures at 16–24 days after initial inoculation (Table 2). These
observations reveal the feasibility of cultivation of Borrelia
spirochetes from skin specimens of chronic skin lesions presenting
as morphea-like cutaneous manifestations.
The existence of two tandemly duplicated copies of rrl (23S) and
rrf (5S) genes in B. burgdorferi sensu lato is unique and has not been
found in other members of the genus Borrelia or in other
eubacteria.10,11 Taking advantage of this unique genomic charac-
ter, the genetic identity of Borrelia spirochetes can be distinguished
by their differential reactivities with genospecies-speciﬁc PCR
primers targeting the 5S (rrf)–23S (rrl) intergenic spacer amplicon
gene. Indeed, genetic heterogeneity can be further classiﬁed
among Borrelia isolates that were previously identiﬁed as the same
genospecies or atypical strains of Borrelia spirochetes.13,14 Results
from the present study also clarify that the genetic identities of
Borrelia spirochetes isolated from skin biopsy specimens of
Taiwanese patients are highly homogeneous within the genos-
pecies of B. burgdorferi sensu stricto and B. afzelii, and were clearly
distinguished from other genospecies of Borrelia spirochetes
(Table 3). Further application of these genospecies-speciﬁc PCR
primers to analyze the rrf–rrl genes of Borrelia spirochetes isolated
from various reservoir hosts and tick specimensmay help to clarify
the genetic divergence of Borrelia spirochetes in the natural
transmission cycle in Taiwan.
Although the actual role of B. burgdorferi in the etiopathogenesis
of morphea remains controversial, the skin lesions of morphea
share many clinical and histopathological characteristics withlated from humans and strains of other genospecies of Borreliaa
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Figure 2. Phylogenetic relationships based on a comparison of the 5S (rrf)–23S (rrl) rRNA gene sequences between two Borrelia spirochetes (Bbss-MP-TW and Ba-MP-TW)
isolated from humans in Taiwan and 22 other strains of Borrelia spirochetes. The trees were constructed and analyzed by the neighbor-joining (A) and maximum parsimony
(B)methods using 1000 bootstrap replicates. Numbers at the nodes indicate the percentages of reliability of each branch of the tree. Branch lengths are drawn proportional to
the estimated sequence divergence.
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dermatosis associated with B. burgdorferi infection.33 Indeed, the
possible association of B. burgdorferi in the pathogenesis of
morphea has been assumed by serological detection of antibodies
against B. burgdorferi in patients with long-lasting morphea33 and
by successful isolation of Borrelia spirochetes from patients with
morphea.32 In addition, the etiological association of B. burgdorferiwith morphea has also been reported in Europe, Japan, and Turkey
by DNA ampliﬁcation with PCR targeting the ﬂagellin gene of B.
burgdorferi sensu lato.34–36 In the present study, B. burgdorferiwas
isolated from skin specimens of patients with skin lesions
sustained for 3–5 years, and Borrelia species were also veriﬁed
by a nested PCR targeting the 5S–23S intergenic spacer amplicon
gene of B. burgdorferi sensu lato. These results suggest that
L.-L. Chao et al. / International Journal of Infectious Diseases 15 (2011) e182–e187 e187B. burgdorferi may play a role in the pathogenesis of morphea-like
cutaneous manifestations in Taiwan.
PCR analysis has proved to be useful for investigating the role of
B. burgdorferi in the pathogenesis of many dermatologic manifes-
tations of Lyme borreliosis. Although the etiology of morphea has
been related to B. garinii and B. afzelii in Europe and Japan, B.
burgdorferi DNA was undetectable in patients with morphea in
North America.34 These contradictory results regarding the
detection of B. burgdorferi DNA from patients with morphea
may be attributed to the speciﬁc primers used for the PCR analysis.
Indeed, the present study employed nested PCR primers targeting
the unique tandemly repeated 5S–23S intergenic spacer amplicon
genes in B. burgdorferi sensu lato, and B. burgdorferi sensu stricto
and B. afzelii were detected in patients with morphea-like
manifestations in Taiwan. Further application of this molecular
tool to detect B. burgdorferi DNA from patients with morphea-
related skin lesions collected from different countries may help to
clarify the etiologic relationship between B. burgdorferi infection
and morphea.
In summary, our isolation and identiﬁcation of B. burgdorferi
sensu stricto and B. afzelii from human tissues should remind
physicians to consider Lyme borreliosis in the differential
diagnosis of patients with chronic skin lesions. Furthermore, our
ﬁndings also highlight the increasing demand for further
investigations focused on the detection of Borrelia spirochetes
among patients characterized with various clinical manifestations
associated with B. burgdorferi infection. We anticipate these
studies would help to elucidate the genetic diversity of the
genospecies of Borrelia spirochetes in the Taiwan area.
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